Amgen (AMGN)
(Delayed Data from NSDQ)
$271.48 USD
+2.55 (0.95%)
Updated Apr 22, 2024 11:55 AM ET
After-Market: $272.00 +0.52 (0.19%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum D VGM
Price, Consensus and EPS Surprise
AMGN 271.48 +2.55(0.95%)
Will AMGN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMGN
Why Amgen (AMGN) Outpaced the Stock Market Today
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Should You Invest in the VanEck Biotech ETF (BBH)?
Other News for AMGN
Goldman’s debt issuers stocks basket
Gilead Sciences: Some Signs Of An Impending Bottom
Dividend yield and growth stock list by Goldman
March 2025 Options Now Available For Amgen (AMGN)
Piper Sandler Sticks to Its Buy Rating for Amgen (AMGN)